Biotechnology firm Genzyme leaders discuss funding clinical trials for a new version of a medical device called Synvisc. The trial of the road and the chances of success are low, but the upside is substantial. Case is the general question of business: invest or not? The case forces students to deal with complex issues and analysis of the financial performance of their solutions. "Hide
by Tim Calkins, Anne Deming Source: Kellogg School Management 15 pages. Publication Date: January 26, 2010. Prod. #: KEL439-PDF-ENG
Related Case Solutions & Analyses:
Adam Root MD (B)
Southern Cross Latin America Private Equity Fund
Bang Networks: The First Customer (A)
GEs Early Dispute Resolution Initiative (B)
Leaders Guide to Understanding Complex Organizations: An Expanded 7-S Perspective
BMW AG: The Digital Auto Project (A)
Erik Peterson at Biometra (A)
PLAY IT SAFE AT HOME, OR TAKE A RISK ABROAD?
Hillside Hospital
Siemens CerberusEco in China: Introducing low-frills products in a high-quality company
